LSK Investment

Developer of ribonucleic acid-based therapeutics intended to treat neurodegenerative diseases. The company's therapeutics include candidates for Alzheimer's disease, m-ribonucleic acid vaccine and drug delivery systems for ribonucleic acid candidates, enabling doctors to improve the health of humankind.

Rznomics is a biotechnology company founded by professor Lee Sung-wook's lab, focusing on the development of innovative gene therapy products aimed at treating liver cancer and other serious medical conditions. The company specializes in ribonucleic acid-based therapies that address significant unmet medical needs, particularly in the areas of cancer, degenerative neurological disorders, and hereditary diseases. By creating new biopharmaceuticals, Rznomics aims to provide medical practitioners with effective treatment options for challenging health issues, including various types of cancer and Alzheimer’s disease. The company has garnered recognition for its technological excellence, having been selected for the TIPS program, which highlights its commitment to advancing medical science.

Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.

PeLeMed is a drug development company working on the discovery of anti-cancer drugs. The company's innovative therapeutic candidates through type 1 kinase inhibitor development platform.

Operator of a surgical data platform intended to improve diagnosis through digital innovation. The company's platform specializes in robotics and laparoscopic surgery, analytical diagnosis, and a simulated examination of the surgery and provides 3D anatomical images and AI-based surgical analysis reports, enabling medical professionals to manage patient complications more efficiently.

Operator of a surgical data platform intended to improve diagnosis through digital innovation. The company's platform specializes in robotics and laparoscopic surgery, analytical diagnosis, and a simulated examination of the surgery and provides 3D anatomical images and AI-based surgical analysis reports, enabling medical professionals to manage patient complications more efficiently.

Lemon Healthcare is a mobile healthcare service that aims to streamline interactions between patients and medical institutions. The company has developed a software platform that facilitates the entire hospital process, from appointment scheduling to prescription management. It offers features such as appointment reminders and one-click payment options, enhancing convenience for users. Additionally, the platform allows prescriptions to be sent directly to pharmacies and manages claims submissions to insurance providers for reimbursement. By integrating these services, Lemon Healthcare creates a smart healthcare ecosystem that simplifies the patient experience.

Value And Trust Company designs, develops, and manufactures orthotic braces for the treatment of AIS (Adolescent Idiopathic Scoliosis). It offers spinamic, a scoliosis brace device that provides therapy for straightening vertebra curve of the spine. The company offers bracing and support solutions that are used in scoliosis. It also offers Spinamic, an application that enables the patients to monitor device wearing time. Value And Trust Company is based in Seoul, South Korea.

Medizen Humancare Inc. is a research company based in Seoul, South Korea, specializing in genomic analysis for disease prediction on an individual basis. Founded in 2012, the company offers services such as M-CHECK, which assesses patients' risk for genetic diseases by analyzing genomic variations related to specific conditions. This service utilizes gene chips and analysis kits tailored for diverse populations, including Koreans and other ethnic groups. Additionally, Medizen provides MELTHY, a direct-to-consumer DNA analysis service aimed at enhancing disease prevention and promoting health longevity. The company's efforts extend across Asia, the Americas, Europe, and internationally, focusing on the acquisition of disease-specific genomic content, identifying new drug candidate genes, and developing preventive healthcare measures.